Endovascular Aneurysm Repair Market Overview:
Global Endovascular Aneurysm Repair (Evar) Market was valued at $2,327 million in 2016, and is expected to reach at $3,580 million by 2023, registering a CAGR of 6.2% from 2017 to 2023. Endovascular aneurysm repair (EVAR) is a preferred treatment option for aortic aneurysm given its advantages over open surgery. These advantages include shorter hospital stay, quick recovery time, improved patient outcomes, and no abdominal surgery. Hence, this EVAR procedure is known as standard intervention for abdominal aortic aneurysm (AAA). In this procedure, a stent is placed in an aneurysmal area of the aorta to provide permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing.
The technological advancements in the field of EVAR has led to a shift from open surgery to endovascular repair. Hence, the EVAR technique is becoming a common treatment of choice among patients with aneurysm. As per Clifford Buckley (a surgeon in Central Texas Veterans Healthcare System) in 2013, about 65%-88% of the AAA procedure were performed using EVAR. Most commonly this procedure is witnessed among AAA patients as thoracic aneurysm is rarely found. Hence, abdominal aortic aneurysm has captured major part of the EVAR market.
Although EVAR has significantly reduced the operative risks and recovery time as compared to conventional open surgery, but further improvisations in the EVAR can be easily accomplished. This is because there have been cases of endoleaks post EVAR procedure. However, to meet such challenges, the market players have developed next generation and advanced technologies. For instance, Endologix Inc., recently gained FDA approval for its percutaneous endograft delivery system and possess a game challenging, new generation Nellix technology, a first and only endovascular sealing product useful in mitigation of all types of endoleak.
Different Evar Products Developed By Market Players
|Aorfix Endovascular Stent Graft||Abdominal aortic aneurysm (AAA)||Lombard Medical Inc.|
|AFX Endovascular AAA System.||Type III endoleaks, AAA||Endologix, Inc.|
|Endurant II AAA Stent Graft System||Infrarenal abdominal aortic or aorto-iliac aneurysms||Medtronic plc.|
|Gore Excluder AAA Endoprosthesis||Iliac artery aneurysms or aortoiliac aneurysm||W. L. Gore & Associates.|
Anaconda Stent Graft System
|Abdominal Aortic Aneurysm||Terumo Cardiovascular Systems Corporation|
The global endovascular aneurysm repair market is segmented based on indication, products, site, and anatomy. Based on indication, it is classified into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The thoracic aortic aneurysm is categorized into ascending, descending, thoracoabdominal, and thoracic arch aortic aneurysm. Based on site, it is bifurcated into infrarenal and pararenal. The pararenal market is divided into juxtarenal and suprarenal. In terms of anatomy, it is categorized into traditional and complex. By products, the EVAR market is classified into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts, and others. Among indications, the abdominal aortic aneurysm segment occupied dominant share of 77.9% in 2016, and is expected maintain this trend during the forecast period, owing to high occurrences of abdominal aortic aneurysm disease globally.
Global Endovascular Aneurysm Repair Market Segmentation
Drivers, restraints, and opportunities
The impact of drivers is currently moderate but is expected to increase in future and drive the endovascular aneurysm repair market, owing to high prevalence of abdominal aortic aneurysm disease and growth in geriatric population. The impact of restraints is anticipated to reduce during the forecast period as government is taking robust efforts toward improvement of cost structure of EVAR devices and treatment procedures. Furthermore, government is taking initiatives to increase awareness related to availability of aneurysm treatment procedures and devices.
Impact Analysis: Drivers & Restraints
Global endovascular aneurysm repair (EVAR) market: Key product segment
The abdominal aortic aneurysm accounted for a significant share in the global EVAR market, and this trend is expected to continue during the forecast period.
Endovascular Aneurysm Repair (EVAR) Market, By Indication, 2016 (%)
UK Endovascular Aneurysm Repair (EVAR) Market
Rise in mortality rate due to AAA drives the global EVAR market in UK. For instance, about 19,000 death each year occur in UK, among which half of them is due to AAA. Moreover, UK has adopted screening program of National Health Service (NHS) for early detection of abdominal aneurysm. This has helped in quick diagnosis of the disease, thereby leading to the rise in demand for AAA treatment options, such as EVAR. The market in UK is expected to exhibit the highest CAGR of 5.9% from 2017 to 2023.
UK Endovascular Aneurysm Repair (EVAR) Market, 2016-2023 ($Million)
The key players in the global endovascular aneurysm repair (EVAR) market include Medtronic plc., Cook Medical Inc., Endologix, Inc., Lombard Medical, Inc., W. L. Gore & Associates, Inc., Cardinal Health Inc., C. R. Bard, Inc., Merck & Co., Inc., Terumo Corporation, and Abbott Laboratories. The other prominent players in the value chain include Volcano Corporation, Spectranetics International BV, AbbVie Inc., Bolton Medical Inc., and Aptus Endosystems Inc.
- The study provides an in-depth analysis of the global EVAR market, with current trends and future estimations to elucidate the imminent investment pockets.
- A quantitative analysis from 2016 to 2023 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
- Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.
- Porter’s Five Forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.
Endovascular Aneurysm Repair Market Key Segments:
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Ascending Aortic Aneurysm
- Descending Aortic Aneurysm
- Thoracoabdominal Aortic Aneurysm
- Thoracic Arch Aortic Aneurysm
- Percutaneous EVAR
- Fenestrated EVAR
- Aortic Stents & TAA grafts
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Republic of South Africa
- Rest of LAMEA